NNuubo — Series B (estimated) · €252K partial: only one investor's ticket was disclosed
CDTI's Innvierte closed a €252K co-investment in Smart Solutions Technologies (Nuubo) with CRB Bio II in Q1 2021, reported 7 April 2021. Only CDTI's ticket was disclosed. CDTI later described Nuubo as having raised just over €9M over 2021-2022; the stage is inferred.
Lead not disclosed
RoundSeries B (estimated)
Announced7 Apr 2021
CityMadrid
SectorHealthtech & Bio · Healthtech / Medical devices
Source
C
